![Matthew Murphy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 140 979 $ al 30/06/2026
Matthew B. Murphy is General Counsel at Nautilus Biotechnology, Inc. since 2021.
Formerly, Mr. Murphy was Vice President-Legal Affairs at Nanosys, Inc., Secretary, General Counsel & Vice President at 10X Genomics, Inc. from 2014 to 2016, Associate Attorney at Townsend & Townsend & Crew LLP, Vice President-Intellectual Property at Caliper Technologies Corp., General Counsel at BioElectron Technology Corp.
from 2016 to 2018, Vice President-Legal at Siluria Technologies, Inc. from 2012 to 2014, and General Counsel at Pacific Biosciences of California, Inc. from 2005 to 2012.
Education includes undergraduate studies at the University of California, Davis and graduate studies at the University of San Francisco School of Law.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 02/03/2026 | 75.390 ( 0,06 % ) | 140 979 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Consejero General | 09/06/2021 |
| Empresas | Cargo | Fin |
|---|---|---|
BioElectron Technology Corp.
 BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic treatments for inherited mitochondrial diseases primarily affecting children | Consejero General | 01/07/2018 |
| 10X GENOMICS, INC. | Consejero General | 01/07/2016 |
Siluria Technologies, Inc.
 Siluria Technologies, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures a direct chemical process for plastics and fuels from natural gas | Consejero General | 01/02/2014 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Consejero General | 01/01/2012 |
Townsend & Townsend & Crew LLP
 Townsend & Townsend & Crew LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Consejero General | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
Nanosys, Inc.
 Nanosys, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures inorganic nanostructures and other related products | Process Industries |
Pacific Biosciences of California, Inc.
 Pacific Biosciences of California, Inc. Medical SpecialtiesHealth Technology Designs, develops and manufactures sequencing system products to help scientists to resolve genetically complex problems | Health Technology |
Siluria Technologies, Inc.
Siluria Technologies, Inc. Chemicals: SpecialtyProcess Industries Develops and manufactures a direct chemical process for plastics and fuels from natural gas | Process Industries |
10X Genomics, Inc.
 10X Genomics, Inc. BiotechnologyHealth Technology Develops integrated systems and solutions for genome sequencing, exome sequencing and single cell transcriptomics | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Townsend & Townsend & Crew LLP
Townsend & Townsend & Crew LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Caliper Technologies Corp.
 Caliper Technologies Corp. Medical SpecialtiesHealth Technology A leading provider of microfluidic technology and laboratory automation solutions serving a broad range of markets in the worldwide life science, biotechnology and pharmaceutical industries. | Health Technology |
University of San Francisco School of Law
 University of San Francisco School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioElectron Technology Corp.
BioElectron Technology Corp. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic treatments for inherited mitochondrial diseases primarily affecting children | Commercial Services |
Nautilus Biotechnology, Inc.
 Nautilus Biotechnology, Inc. BiotechnologyHealth Technology Develops proteomics platform for analyzing and quantifying the human proteome | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
